Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer.
This report contains market size and forecasts of Cancer Immunotherapy in Global, including the following market information:
Global Cancer Immunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Immunotherapy market was valued at 78150 million in 2021 and is projected to reach US$ 131790 million by 2028, at a CAGR of 7.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Immunotherapy include Amgen, AstraZeneca, Roche, Bayer, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis and Pfizer. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Immunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Immunotherapy Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Global Cancer Immunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Immunotherapy Market Segment Percentages, by Application, 2021 (%)
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma
Prostate Cancer
Others
Global Cancer Immunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Immunotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Immunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Immunotherapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
AstraZeneca
Roche
Bayer
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer